Is it possible to shorten the recovery period for "REM Decivir"? New Corona May 23 11:11
With regard to "lemdecibir," which is expected to be a therapeutic drug for new coronavirus, research groups such as NIH = US National Institutes of Health have announced the results of clinical trials that have been shown to be effective in shortening the recovery period of patients. ..
"Lemdecivir" has been shown to have the effect of suppressing the growth of the new coronavirus in the experiment, so clinical trials are underway as it may be used to treat patients.
On the 22nd, research groups such as NIH published the results of the initial stage of clinical trials in the American medical journal "New England Journal of Medicine".
The study was mainly conducted in about 1,000 severely ill patients, and was divided into a group that received lemdecivir and a group that did not, and the course was observed for about 4 weeks after 10 days of drug administration.
As a result, the median time to discharge is 11 days for the group receiving lemdecivir and 4 days shorter than the 15 days for the group not receiving it, which is effective in shortening the recovery period of patients. It is supposed to be seen.
Also, the proportion of patients who died 14 days after the start of the study was lower in the group of patients receiving lemdecivir, but not significantly different from the group not receiving it.
Based on these results, the research group said that “effectiveness of lemdecivir was shown”, and that administration was started before the ventilator was needed, and in parallel with administration of lemdecivir to reduce the mortality rate. He needs to develop other therapies that should be done.
Remdesibir has already been approved for emergency use in the United States, and has been approved as a therapeutic drug in Japan based on the US license.